Michelle LaSpaluto - Dec 1, 2023 Form 3 Insider Report for CHIMERIX INC (CMRX)

Role
Chief Financial Officer
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
3
Date filed
12/4/2023, 05:25 PM
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CMRX Common Stock 87.9K Dec 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 9K $18.75 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 750 $36.75 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 9K $39.41 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 1.5K $53.74 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 15K $53.74 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 18.7K $8.06 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 1.25K $4.51 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 13K $4.68 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 8.1K $2.41 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 48.4K $2.49 Direct F2
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 62.1K $2.08 Direct F3
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 90K $9.28 Direct F4
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 95K $5.62 Direct F4
holding CMRX Stock Option (Right to Buy) Dec 1, 2023 Common Stock 64.3K $1.97 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount includes 10,725 unvested shares pursuant to a restricted stock unit award issued on January 17, 2023.
F2 Fully vested and exercisable.
F3 1/48th of the shares will vest each month over a four year period following the vesting commencement date. This stock option was previously exercised as to 25,933 shares.
F4 1/48th of the shares will vest each month over a four year period following the vesting commencement date.